Scailyte

company

About

True precision medicine through single-cell science

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
Fr600K
Industries
Artificial Intelligence,Biotechnology,Health Care,Health Diagnostics,Medical
Founded date
Jun 19, 2017
Number Of Employee
11 - 50
Operating Status
Active

Scailyte has established a data-driven biomarker discovery platform that leverages unique expertise in single-cell data analysis and artificial intelligence. We are utilizing this platform to discover a new class of biomarkers, which are defined by the molecular profiles of disease-associated cells. This phenotypic approach to biomarker discovery is radically new and directly related to the biology of a disease, which maximizes the success rate for discovering sensitive and robust biomarkers.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Fr600K
Scailyte has raised a total of Fr600K in funding over 2 rounds. Their latest funding was raised on Aug 12, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 12, 2020 Seed Fr600K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Scailyte is funded by 1 investors. Verve Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Verve Ventures Seed